Clinical trial
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
NCT00342992 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00342992 |
|---|---|
| Title | Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study |
| Official title | Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC Study) Population |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | Finnish Institute for Health and Welfare |
| Status | Completed |
| Study type | Observational |
| Conditions | Stroke, Diabetes Mellitus, Heart Disease, Cancer |
| Enrollment | 29,133 |
| Start date | Mar 3, 1995 |
| Primary completion | Sep 4, 2020 |
| Completion | Sep 4, 2020 |
| First posted | Jun 21, 2006 |
| Last update posted | Sep 9, 2020 |
| Countries | Finland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: